The prognostic role of p53R2 in stages I–III NSCLC patients was investigated by Uramoto et al. [12] who concluded that p53R2 did not play an important prognostic role and that the pathway mediated by p53R2 may be responsible for controlling the growth of lung cancer. The gene discussed is RRM2B; the disease is non-small cell lung carcinoma.